AMMAN – Nizar Mheidat, director-general of the
Jordan Food and Drug Administration (JFDA), stated that Jordan intends to
produce expensive medicinal medications at lower costs, Al-Mamlaka TV reported.
اضافة اعلان
According to Mheidat, the Kingdom produces over 1,100
pharmaceutical items falling within this category. These therapeutic
medications have a substantial impact on total healthcare expenditure in the
public sector, which amounts to around JD140-150 million every year. The funds
are mostly used to purchase medications.
Approximately 8,000 of the registered and priced medications
are "generic" and cost less than JD10. The other medications,
totaling 1,100, are vital but more expensive.
In addition, some medications are still unregistered but are imported regularly
for government tenders. These unlicensed medications include 154 different
varieties.
Recently, initiatives have been implemented to speed up the
registration process for emergency use, allowing for faster access to critical
pharmaceuticals.
Other JFDA
initiatives
In terms of food safety and inspections, the JFDA directly
oversees roughly 64,000 food facilities. In 2023 alone, there were over 96,000
inspections of food, pharmaceutical, and medical supply businesses. The closure
rate for non-compliant establishments remains relatively low, at less than 1
percent, substantially below than international estimates.
Furthermore, in preparation for Ramadan, the JFDA performed
inspections of major food warehouses to guarantee that the products entering
the market were safe and fit for consumption.
Finally, when it came to unfit rice for human consumption,
Mheidat stressed the enormous burden placed on the private sector as a result
of this issue. Even if only this amount of unsuitable rice existed in Jordan,
it would have to be destroyed to meet safety regulations.
Read more National news
Jordan News
.jpg)
.jpg)
